E2F1 induces the phosphorylation of p53. (A) Primary MEF cultures wild type for ARF (lanes 1 and 2) or null for ARF (lanes 3 and 4) were coinfected with Adp53 (MOI of 25) and either AdGFP (lanes 1 and 3; MOI, 50) or AdE2F1 (lanes 2 and 4; MOI, 50). At 24 h postinfection, lysates were made and Western blot analysis was performed using antibodies specific for E2F1, p53, phosphoserine 15 p53, phosphoserine 20 p53, phosphoserine 392 p53, or ras where indicated. (B) Western blot analysis was performed on epidermal lysates (100 μg) from mice that were nontransgenic (lanes 1 and 2) or K5 E2F1 transgenic (lanes 3 and 4) and either wild type (lanes 1 and 3) or null (lanes 2 and 4) for ARF by using an antibody specific for the phosphoserine 15 form of p53. NS, nonspecific band. (C) Primary MEFs, either wild type for ARF (lanes 1 to 6) or null for ARF (lanes 7 to 12), were infected with the following recombinant adenoviruses: lanes 1 and 7, AdGFP (MOI, 200); lanes 2 and 8, AdE2F1 (MOI, 50) plus Adp53 (MOI, 25); lanes 3 and 9, Adp53 (MOI, 25); lanes 4 and 10, Adp53 (MOI, 50); lanes 5 and 11, Adp53 (MOI, 100); lanes 6 and 12, Adp53 (MOI, 200). At 24 h following infection, cell lysates were made and Western blot analysis was performed using antibodies specific for p53 (top panel), the serine 20-phosphorylated form of p53 (middle panel), or β-actin (bottom panel).